The DuraClone B27 Reagent Kit is a state-of-the-art diagnostic tool designed for the detection of HLA-B27 in human whole blood samples. Utilizing dry powder flow cytometry, this kit offers high precision and reliability, making it an essential tool in clinical diagnostics. The kit includes all necessary components for efficient and accurate testing, ensuring ease of use and consistent results.

1. The DuraClone B27 Reagent Kit is characterized by its high sensitivity and specificity, ensuring accurate detection of HLA-B27. The dry powder format of the test tubes enhances stability and shelf life, making it a reliable choice for clinical laboratories.
2. The kit consists of 50 single-use dry DuraClone B27 test tubes and a 25 mL bottle of DuraLyse hemolytic agent. These components are specifically designed to work together in flow cytometry, providing a streamlined and efficient testing process.
3. The primary use of this kit is for the qualitative detection of HLA-B27 in whole blood samples. It is widely used in the diagnosis and monitoring of autoimmune diseases, such as ankylosing spondylitis, where HLA-B27 plays a critical role.

The DuraClone B27 Reagent Kit, also known as the HLA-B27 Test Kit, is a highly reliable diagnostic tool for detecting HLA-B27 in whole blood samples. Its dry powder format and comprehensive components make it a preferred choice in clinical settings, ensuring accurate and consistent results.

The DuraClone B27 Reagent Kit offers high sensitivity and specificity for HLA-B27 detection, with a dry powder format that ensures stability and ease of use.

1. High Sensitivity: The kit is designed to detect even low levels of HLA-B27, ensuring accurate results in clinical diagnostics.
2. Dry Powder Format: The dry powder test tubes enhance the stability and shelf life of the reagents, making the kit more reliable over time.
3. Comprehensive Components: The kit includes all necessary components, such as DuraLyse hemolytic agent, for a complete and efficient testing process.
4. Ease of Use: The streamlined design of the kit allows for straightforward and efficient testing, reducing the potential for user error.
5. Reliable Results: The kit is optimized for flow cytometry, ensuring consistent and reliable results in clinical settings.

The DuraClone B27 Reagent Kit stands out for its high sensitivity, dry powder format, and comprehensive components. These features make it an essential tool for accurate and reliable HLA-B27 detection in clinical diagnostics.

The DuraClone B27 Reagent Kit is widely used in clinical settings for the diagnosis and monitoring of autoimmune diseases related to HLA-B27.

1. Diagnosis of Ankylosing Spondylitis: The kit is commonly used to diagnose ankylosing spondylitis, a condition strongly associated with HLA-B27.
2. Monitoring Autoimmune Diseases: It is also used to monitor the progression of other autoimmune diseases where HLA-B27 plays a role.
3. Research Applications: The kit is utilized in research studies to better understand the role of HLA-B27 in various autoimmune conditions.
4. Clinical Trials: It is often used in clinical trials to assess the efficacy of new treatments for HLA-B27-related diseases.
5. Routine Screening: The kit is employed in routine screening programs to identify individuals at risk for HLA-B27-related conditions.

The DuraClone B27 Reagent Kit is a versatile tool in clinical diagnostics, widely used for the diagnosis and monitoring of HLA-B27-related autoimmune diseases. Its applications extend to research and clinical trials, making it a valuable asset in the medical field.

The DuraClone B27 Reagent Kit is designed for clinical laboratories and research institutions, offering a reliable and efficient solution for HLA-B27 detection.

1. Product Parameters: The kit includes 50 single-use dry DuraClone B27 test tubes and a 25 mL bottle of DuraLyse hemolytic agent, optimized for flow cytometry.
2. Product Types: The kit is available in various configurations to meet the specific needs of different laboratories and research institutions.
3. Procurement Budget: The cost of the kit is competitive, offering a cost-effective solution for HLA-B27 detection in clinical settings.
4. Usage Scenarios: The kit is suitable for use in clinical diagnostics, research studies, and clinical trials, providing a versatile solution for HLA-B27 detection.

The DuraClone B27 Reagent Kit is a cost-effective and versatile solution for HLA-B27 detection, suitable for a wide range of clinical and research applications. Its comprehensive components and competitive pricing make it a preferred choice for laboratories and research institutions.

Proper handling and storage of the DuraClone B27 Reagent Kit are essential to ensure accurate and reliable results.

1. Storage Conditions: The kit should be stored at the recommended temperature to maintain the stability of the reagents.
2. Handling Procedures: Proper handling procedures should be followed to avoid contamination and ensure accurate results.
3. Disposal of Waste: Used test tubes and other waste materials should be disposed of according to local regulations and guidelines.
4. User Training: Users should be adequately trained in the use of the kit to minimize the risk of errors and ensure consistent results.
5. Quality Control: Regular quality control checks should be performed to ensure the reliability and accuracy of the test results.

The DuraClone B27 Reagent Kit requires careful handling and storage to ensure accurate and reliable results. Proper training, quality control, and adherence to disposal guidelines are essential for optimal performance and safety in clinical settings.